BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16757141)

  • 1. Chlamydia pneumoniae antibody levels before coronary events in the Helsinki Heart Study as measured by different methods.
    Paldanius M; Leinonen M; Virkkunen H; Tenkanen L; Sävykoski T; Mänttäri M; Saikku P
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):233-9. PubMed ID: 16757141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlamydia pneumoniae serology: comparing a commercial enzyme immunoassay and microimmunofluorescence test in patients with cardiovascular disease.
    Vainas T; De Graaf R; Stassen FR; Kurvers HA; Grauls GE; Kitslaar PJ; Bruggeman CA
    APMIS; 2003 Feb; 111(2):363-9. PubMed ID: 12716394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of chlamydial LPS antibodies in patients with acute coronary syndrome without detection of chlamydial DNA in atherectomy samples.
    Kiss K; Khanakah G; Kundi M; Glogar HD; Stanek G
    Wien Klin Wochenschr; 2001 Oct; 113(19):731-6. PubMed ID: 11715751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results.
    Peeling RW; Wang SP; Grayston JT; Blasi F; Boman J; Clad A; Freidank H; Gaydos CA; Gnarpe J; Hagiwara T; Jones RB; Orfila J; Persson K; Puolakkainen M; Saikku P; Schachter J
    J Infect Dis; 2000 Jun; 181 Suppl 3():S426-9. PubMed ID: 10839729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlamydia pneumoniae IgA- and IgG antibodies in young survivors of myocardial infarction. A comparison of antibody detection by a microimmunofluorescence test and an enzyme immunoassay.
    Halvorsen DS; Børvik T; Njølstad I; Gutteberg TJ; Vorland LH; Hansen JB
    J Intern Med; 2002 Feb; 251(2):142-7. PubMed ID: 11905590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes.
    Wong BY; Gnarpe J; Teo KK; Ohman EM; Prosser C; Gibler WB; Langer A; Chang WC; Armstrong PW
    Am Heart J; 2002 Dec; 144(6):987-94. PubMed ID: 12486422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microimmunofluorescence test for Chlamydia pneumoniae infection: technique and interpretation.
    Wang Sp
    J Infect Dis; 2000 Jun; 181 Suppl 3():S421-5. PubMed ID: 10839728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two microimmunofluorescence tests for detecting antibodies to Chlamydia pneumoniae.
    Monno R; Sibilio G; Costi A; D'Aprile A; De Vito D; Marcuccio P; Rizzo G
    New Microbiol; 2002 Jul; 25(3):299-306. PubMed ID: 12173771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum reactivity to Chlamydia trachomatis and C. pneumoniae antigens in patients with documented infection and in healthy children by microimmunofluorescence and immunoblotting techniques.
    Gonen R; Shemer-Avni Y; Csángó PA; Sarov B; Friedman MG
    APMIS; 1993 Sep; 101(9):719-26. PubMed ID: 8240791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases.
    Romano Carratelli C; Nuzzo I; Cozzolino D; Bentivoglio C; Paolillo R; Rizzo A
    Int Immunopharmacol; 2006 May; 6(5):848-53. PubMed ID: 16546716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlamydophila pneumoniae diagnostics: importance of methodology in relation to timing of sampling.
    Hvidsten D; Halvorsen DS; Berdal BP; Gutteberg TJ
    Clin Microbiol Infect; 2009 Jan; 15(1):42-9. PubMed ID: 19046171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and optimization of ELISA for detection of anti-Chlamydophila pneumoniae IgG and IgA in patients with coronary heart diseases.
    Ciervo A; Petrucca A; Visca P; Cassone A
    J Microbiol Methods; 2004 Oct; 59(1):135-40. PubMed ID: 15325761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a new commercial EIA kit and the microimmunofluorescence technique for the determination of IgG and IgA antibodies to Chlamydia pneumoniae.
    Gnarpe J; Nääs J; Lundbäck A
    APMIS; 2000 Dec; 108(12):819-24. PubMed ID: 11252815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serological tests for detection of immunoglobulin M antibodies to Chlamydophila pneumoniae.
    Miyashita N; Ouchi K; Kawasaki K; Komura H; Kawai Y; Tsumura N; Bannai H; Iwata S; Oka M
    Respirology; 2008 May; 13(3):427-31. PubMed ID: 18399867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of methodology in determination of Chlamydia pneumoniae seropositivity in healthy subjects and in patients with coronary atherosclerosis.
    Hoymans VY; Bosmans JM; Van Renterghem L; Mak R; Ursi D; Wuyts F; Vrints CJ; Ieven M
    J Clin Microbiol; 2003 Sep; 41(9):4049-53. PubMed ID: 12958224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serodiagnosis of Chlamydia trachomatis and Chlamydia pneumoniae. Evaluation comparing 2 methods: microimmunofluorescence and ELISA. A study of 216 Congolese sera].
    Biendo M; Orfila J
    Bull Soc Pathol Exot; 1994; 87(2):81-4. PubMed ID: 8061532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.
    Saikku P; Leinonen M; Tenkanen L; Linnanmäki E; Ekman MR; Manninen V; Mänttäri M; Frick MH; Huttunen JK
    Ann Intern Med; 1992 Feb; 116(4):273-8. PubMed ID: 1733381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland.
    Paldanius M; Bloigu A; Alho M; Leinonen M; Saikku P
    Clin Diagn Lab Immunol; 2005 May; 12(5):654-9. PubMed ID: 15879028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of enzyme linked immunosorbent assays species specific in the detection of Chlamydia trachomatis and Chlamydophila pneumoniae IgG antibodies in patients with genital infections or respiratory tract infections.
    Frikha-Gargouri O; Znazen A; Gdoura R; Gargouri B; Arab NB; Jemaa MB; Hammami A
    Pathol Biol (Paris); 2008 May; 56(3):143-7. PubMed ID: 18178034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new microimmunofluorescence test for the detection of Chlamydia pneumoniae specific antibodies.
    Fernández F; Gutiérrez J; Mendoza J; Linares J; Soto MJ
    J Basic Microbiol; 2004; 44(4):275-9. PubMed ID: 15266599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.